WW International, Inc/$WW

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About WW International, Inc

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

Ticker

$WW
Sector
Consumer Discretionary
Primary listing
NASDAQ

Employees

3,700
Headquarters
New York, United States
Website
corporate.ww.com

WW Metrics

BasicAdvanced
$326M
2.36
$13.86
-
-

Bulls say / Bears say

Clinical subscription revenue jumped 55.1% year-over-year to $31 million in Q2 2025, fueled by rising compounded semaglutide subscriptions and an early move to FDA-approved medications. This reflects WW’s successful shift into medical weight management. (Reuters)
WW completed its financial restructuring in June 2025, cutting $1.15 billion in debt and significantly strengthening its balance sheet to enable future investments. (Reuters)
The hiring of Dr. Kim Boyd as Chief Medical Officer and the launch of a dedicated menopause program positions WW to serve an underserved demographic and expands its women’s health offerings. (Reuters)
Subscriber numbers fell 12% to 3.3 million in 2024, highlighting ongoing member attrition and weakening WW's core behavioral business model. (FT)
Intense competition from GLP-1 weight-loss drugs such as Ozempic and Wegovy has disrupted WW's traditional in-person workshops, pushing the company to integrate drug-based solutions that may not fully compensate for the drop in behavioral program revenues. (FT)
The Chapter 11 bankruptcy filing in May 2025 has damaged WW's brand and shaken investor confidence, with shares falling more than 60% since April over uncertainty about the company's strategy. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 25 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $WW

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs